Two mAbs take a stab at influenza's NActive site
Minh C Pham1, Kevin C O'Connor1
1Departments of Neurology and Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA. Email: minh.pham@yale.edu; kevin.oconnor@yale.edu.
Science Immunology
|November 7, 2020
Summary
Two human monoclonal antibodies (mAbs) targeting the infectious bronchitis virus (IBV) neuraminidase active site provide broad protection by mimicking the enzyme's substrate.
Area of Science:
- Virology
- Immunology
- Biochemistry
Background:
- Infectious bronchitis virus (IBV) poses a significant threat to poultry production.
- Neuraminidase (NA) is a key surface protein of IBV, crucial for viral replication and pathogenesis.
- Developing effective therapeutic strategies against IBV requires a deep understanding of its NA structure and function.


